REQUEST A DEMO
Total
USD $0.00
Search more companies

Plus Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Plus Pharma Sp. z o.o. Profile Updated: August 09, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Plus Pharma Sp. z o.o. is based in Poland. The head office is in Elizowka. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The enterprise was incorporated on April 28, 2017. In its most recent financial highlights, the company reported a net sales revenue increase of 55.49% in 2023. Its total assets grew by 20439.8% over the same period. In, 2023, the company’s net profit margin increased by 5.82%.

Headquarters
Ul. Szafranowa 6
Elizowka; Lubelskie; Postal Code: 21-003

Contact Details: Purchase the Plus Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Plus Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Plus Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 28, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Plus Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
55.49%
Total operating revenue
62.71%
Operating profit (EBIT)
944.56%
Net Profit (Loss) for the Period
944.57%
Total assets
20439.8%
Total equity
46.05%
Operating Profit Margin (ROS)
5.82%
Net Profit Margin
5.82%
Return on Equity (ROE)
-146.96%
Quick Ratio
0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?